The Cubicin Outcomes Registry and Experience (CORE), a retrospective observational record review of patients with serious Gram-positive infections treated with daptomycin in the real-world setting at 70 separate institutions in the United States from January 2005 through December 2009.

Trial Profile

The Cubicin Outcomes Registry and Experience (CORE), a retrospective observational record review of patients with serious Gram-positive infections treated with daptomycin in the real-world setting at 70 separate institutions in the United States from January 2005 through December 2009.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Apr 2016

At a glance

  • Drugs Daptomycin (Primary)
  • Indications Gram-positive infections
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms CORE
  • Most Recent Events

    • 12 Apr 2016 Results of pooled analysis of CORE and EU-CORE registries (n=11557) presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases
    • 26 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top